THE USE OF COMBINED HORMONAL CONTRACEPTIVES AND OCCURRENCE OF METABOLIC SYNDROME: A NARRATIVE REVISION (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorSousa, Carla Roberta Macedo de-
Autor(es): dc.contributor.authorRocha, Liana Gonçalves Aragão-
Autor(es): dc.contributor.authorLima, Aline Felismino-
Autor(es): dc.contributor.authorSabóia, Antonio Lucas Albuquerque-
Autor(es): dc.contributor.authorMedeiros, Francisco das Chagas-
Autor(es): dc.contributor.authorLinhares, José Juvenal-
Data de aceite: dc.date.accessioned2021-11-17T20:34:43Z-
Data de disponibilização: dc.date.available2021-11-17T20:34:43Z-
Data de envio: dc.date.issued2021-11-10-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/643213-
Resumo: dc.description.abstractObjective: The goal of this revision is to explain if the use of combined hormonal contraceptives (CHCs) can be correlated to metabolic alterations that may have an association on the occurrence of metabolic syndrome. Methods: Articles published between January 2008 and September 2020 identified in Google Scholar, Scielo, Pubmed, and Cochrane databases were enlisted and narrowed down to 28 selected articles and one Ph.D. thesis. Results: The use of CHCs may influence carbohydrate metabolism, lipid profile, and changes in C-reactive protein (CRP), however, the influence of CHCs on abdominal circumference, blood pressure, and the prevalence of metabolic syndrome is unclear. Conclusions: The results found were controversial in most of the investigated cases of metabolic alterations. Therefore, there is no association between the use of CHCs and the occurrence of metabolic syndrome.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectMETABOLISMpt_BR
Título: dc.titleTHE USE OF COMBINED HORMONAL CONTRACEPTIVES AND OCCURRENCE OF METABOLIC SYNDROME: A NARRATIVE REVISION (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais